Artificial Pancreas Device System Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Artificial Pancreas Device System Market By 2029?

The artificial pancreas device system market has experienced substantial expansion in recent years. Its valuation is projected to increase from $1.81 billion in 2024 to $2.06 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.8%. The expansion observed historically can be credited to an escalating influx of investment, burgeoning governmental support for clinical research, a rising need for automated glycemic control systems, vigorous R&D undertakings by industry participants, and the increasing elderly demographic.

The artificial pancreas device system market is anticipated to observe significant expansion over the next few years, with its valuation expected to reach $3.46 billion by 2029 at a compound annual growth rate (CAGR) of 13.8%. This projected growth throughout the forecast period stems from the increasing prevalence of diabetes, a rise in pancreatic cancer cases, the growing occurrence of diabetes and obesity, an elevated demand for minimally invasive (MI) drug delivery systems, and ongoing innovation in diabetes management technology. Key trends foreseen during this period encompass technological advancements, intensified research and development activities, an increase in product approvals, strategic partnerships and collaborations, and expanded teleconsultancy services for patient follow-up.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

Which Factors And Drivers Are Influencing The Artificial Pancreas Device System Market In 2025?

The rising occurrence of pancreatic cancer is anticipated to boost the growth of the artificial pancreas device system market moving forward. Pancreatic cancer is defined as a malignant tumor originating in the pancreas, which is a gland situated behind the stomach. Its progression is influenced by a combination of lifestyle, genetic, medical, and environmental elements, in addition to genetic mutations that cause hereditary pancreatitis, leading to chronic inflammation of the pancreas. An artificial pancreas device system (APDS) is primarily designed to aid individuals with diabetes in managing their blood sugar levels by automatically monitoring glucose and administering the correct amount of insulin. For example, in March 2024, Cancer Australia, a government agency, estimated 4,506 new cases of pancreatic cancer were diagnosed in 2023, an increase from the 3,751 cases reported over the past five years. Thus, the escalating prevalence of pancreatic cancer is driving the expansion of the artificial pancreas device system market.

What Are The Segment Types Shaping The Artificial Pancreas Device System Market?

The artificial pancreas device systemmarket covered in this report is segmented –

1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems

2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid

3) By End-User: Hospitals; Medical Centers; Other End-Users

Subsegments:

1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend; Continuous Glucose Monitoring (CGM) Integrated Systems

2) By Control-To-Range Systems: Hybrid Closed-Loop Systems; Insulin Delivery Systems with Range Control; Real-Time Glucose Adjustment Systems

3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems; Insulin Pumps with Targeted Glucose Control; Automated Glucose Regulation Systems

What Key Innovation Trends Are Fueling Advancements In The Artificial Pancreas Device System Market?

Major companies in the artificial pancreas device system market are creating automated insulin delivery systems to improve diabetes management. These systems operate by automatically tracking blood glucose levels and dispensing the correct amount of insulin. Automated insulin delivery systems aim to replicate the function of a healthy pancreas, thereby reducing the burden of continuous blood sugar monitoring and manual insulin administration for individuals with diabetes. For instance, in May 2023, Beta Bionics, a US-based medical equipment manufacturing company, received FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System, which is an automated insulin delivery device. This artificial pancreas system is designed to independently determine and deliver insulin doses to control blood glucose levels. As a closed-loop system, it automatically adjusts insulin delivery based on the user’s glucose levels, as measured by a connected continuous glucose monitor (CGM). It only requires the user’s body weight and a meal size estimate for automatic insulin delivery adjustments.

Who Are The Major Companies Operating In The Artificial Pancreas Device System Market?

Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

Which Region Is Projected To Lead The Artificial Pancreas Device System Market During The Forecast Period?

North America was the largest region in the artificial pancreas device system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Artificial Pancreas Device System Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp

Browse Through More Reports Similar to the Global Artificial Pancreas Device System Market 2025, By The Business Research Company

Automotive Artificial Intelligence Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automotive-artificial-intelligence-global-market-report

Artificial Intelligence In Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

Artificial Turf Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-turf-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795